Immunocore Holdings (Immunocore Holdings) PB Ratio : 6.28 (As of May. 12, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Immunocore Holdings PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-12), Immunocore Holdings's share price is $58.95. Immunocore Holdings's Book Value per Share for the quarter that ended in Dec. 2023 was $9.39. Hence, Immunocore Holdings's PB Ratio of today is 6.28.

Good Sign:

Immunocore Holdings PLC stock PB Ratio (=6.33) is close to 1-year low of 5.88

The historical rank and industry rank for Immunocore Holdings's PB Ratio or its related term are showing as below:

IMCR' s PB Ratio Range Over the Past 10 Years
Min: 3.76 Med: 6.87 Max: 20.48
Current: 6.33

During the past 6 years, Immunocore Holdings's highest PB Ratio was 20.48. The lowest was 3.76. And the median was 6.87.

IMCR's PB Ratio is ranked worse than
83.07% of 1311 companies
in the Biotechnology industry
Industry Median: 2.5 vs IMCR: 6.33

During the past 12 months, Immunocore Holdings's average Book Value Per Share Growth Rate was 6.30% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 64.80% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 632.80% per year.

During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Immunocore Holdings was 1908.50% per year. The lowest was 64.80% per year. And the median was 1220.30% per year.

Back to Basics: PB Ratio

Immunocore Holdings PB Ratio Historical Data

The historical data trend for Immunocore Holdings's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunocore Holdings PB Ratio Chart

Immunocore Holdings Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

PB Ratio

Get a 7-Day Free Trial

6.58

6.65

7.28

Immunocore Holdings Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
PB Ratio	Get a 7-Day Free Trial														6.65	7.19	8.38	7.11	7.28

Competitive Comparison of Immunocore Holdings's PB Ratio

For the Biotechnology subindustry, Immunocore Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Immunocore Holdings's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immunocore Holdings's PB Ratio distribution charts can be found below:

* The bar in red indicates where Immunocore Holdings's PB Ratio falls into.

Immunocore Holdings PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Immunocore Holdings's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Dec. 2023)
	=	58.95	/	9.389
	=	6.28

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Immunocore Holdings (NAS:IMCR) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Immunocore Holdings PB Ratio Related Terms

Thank you for viewing the detailed overview of Immunocore Holdings's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunocore Holdings (Immunocore Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunocore Holdings PLC (NAS:IMCR) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

6YG:Germany 6YG:Germany

Address

92 Park Drive, Milton Park, Abingdon, Oxfordshire, GBR, OX14 4RY

Website

https://www.immunocore.com

Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.